[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342562-105":59,"doc-detail-342562-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-ultrasound-based-radiomics-model-to-predict-germline-brca-mutations-in-patients-with-breast-cancer","Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer","","Background: Identifying breast cancer patients with germline breast cancer susceptibility gene (gBRCA) mutations is essential, yet current clinical criteria for germline testing remain controversial. This retrospective study aimed to develop and validate a nomogram that integrates ultrasound radiomic features with clinicopathological factors to predict gBRCA mutations in breast cancer patients. Methods: Data from 497 women undergoing gBRCA genetic testing (training and validation cohorts) were used to derive imaging models and evaluate performance using AUC, calibration, and clinical usefulness. Results: The clinicopathological model and imaging models showed discriminative ability, with the combined 3 mm intratumoral/peritumoral radiomics approach performing best in validation; the nomogram outperformed the clinicopathological model. Conclusion: The proposed ultrasound-based nomogram supports improved clinical decision-making regarding genetic testing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-ultrasound-based-radiomics-model-to-predict-germline-brca-mutations-in-patients-with-breast-cancer/342562/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-ultrasound-based-radiomics-model-to-predict-germline-brca-mutations-in-patients-with-breast-cancer/342562.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study goal?","Question",{"text":112,"@type":113},"To develop and validate a nomogram combining ultrasound radiomics and clinicopathological factors for predicting gBRCA mutations in breast cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were ultrasound radiomics features used?",{"text":117,"@type":113},"Radiomics features were extracted from intratumoral and peritumoral regions at 3 mm and 5 mm, then selected using LASSO and modeled with logistic regression to build imaging models.",{"name":119,"@type":110,"acceptedAnswer":120},"Which predictors contributed to the clinicopathological model?",{"text":121,"@type":113},"Age at diagnosis, family history of breast cancer, personal history of other BRCA-related cancers, and HER2 status were independent predictors in the clinicopathological model.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342562,1790191001,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Deng et al. Cancer Imaging (2024) 24:31 [https://doi.org/10.1186/s40644-024-00676-w](https://doi.org/10.1186/s40644-024-00676-w)  \nCancer Imaging  \n RESEARCH ARTICLE Open Access  \nDevelopment and validation  \nof ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer  \nTingting Deng1†, Jianwen Liang2†, Cuiju Yan1, Mengqian Ni3, Huiling Xiang1, Chunyan Li1, Jinjing Ou1, Qingguang Lin1, Lixian Liu4, Guoxue Tang5, Rongzhen Luo6, Xin An3, Yi Gao2* and Xi Lin 1*  \nAbstract  \nBackground Identifying breast cancer (BC) patients with germline breast cancer susceptibility gene (gBRCA) mutation is important. The current criteria for germline testing for BC remain controversial. This study aimed to develop a nomogram incorporating ultrasound radiomic features and clinicopathological factors to predict gBRCA mutations in patients with BC.  \nMaterials and methods In this retrospective study, 497 women with BC who underwent gBRCA genetic testing from March 2013 to May 2022 were included, including 348 for training (84 with and 264 without a gBRCA mutation) and 149 for validation(36 patients with and 113 without a gBRCA mutation) . Factors associated with gBRCA mutations were identified to establish a clinicopathological model. Radiomics features were extracted from the intratumoraland peritumoral regions (3 mm and 5 mm) of each image. The least absolute shrinkage and selection operator regression algorithm was used to select the features and logistic regression analysis was used to construct three imaging models. Finally, a nomogram that combined clinicopathological and radiomics features was developed. The models were evaluated based on the area under the receiver operating characteristic curve (AUC), calibration, and clinical usefulness.  \nResults Age at diagnosis, family history of BC, personal history of other BRCA-related cancers, and human epidermal growth factor receptor 2 status were independent predictors ofthe clinicopathological model. The AUC ofthe imaging radiomics model combining intratumoral and peritumoral 3 mm areas in the validation set was 0.783 (95% confidence interval [CI]: 0 .702—0. 862), which showed the best performance among three imaging models. The nomogram yielded better performance than the clinicopathological model in validation sets (AUC: 0.824 [0 .755—0. 894] versus 0.659 [0 .563—0. 755], p = 0 . 007) .  \nConclusion The nomogram based on ultrasound images and clinicopathological factors performs well in predicting gBRCA mutations in BC patients and may help to improve clinical decisions about genetic testing.  \n†Tingting Deng and Jianwen Liang contributed equally to this work.  \n*Correspondence: Yi Gao [gaoyi@szu.edu.cn](gaoyi@szu.edu.cn)[ ](gaoyi@szu.edu.cn)Xi Lin [linxi@sysucc.org.cn](linxi@sysucc.org.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Do","cbCaiifFccj7Mype","https://ap.wps.com/l/cbCaiifFccj7Mype","pdf",1475381,11,"English","# Abstract\n## Background\n## Materials and methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the study goal?\",\"answer\":\"To develop and validate a nomogram combining ultrasound radiomics and clinicopathological factors for predicting gBRCA mutations in breast cancer patients.\"},{\"question\":\"How were ultrasound radiomics features used?\",\"answer\":\"Radiomics features were extracted from intratumoral and peritumoral regions at 3 mm and 5 mm, then selected using LASSO and modeled with logistic regression to build imaging models.\"},{\"question\":\"Which predictors contributed to the clinicopathological model?\",\"answer\":\"Age at diagnosis, family history of breast cancer, personal history of other BRCA-related cancers, and HER2 status were independent predictors in the clinicopathological model.\"}]","Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer | PDF",1790047141,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b43a30e2d79f81b3903e48be12937a9c.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab2d9681bcca0cb6bf091dbc17a694e1.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0219f02e3273ff487f264ae9d905cd59.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad4b455ef12b7ac90df541535b24eb0c.webp",980,1301]